Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDZevra Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | $0.01 | $0.16 | $0.08 |
| Q2 2026 | 5 | $0.03 | $0.19 | $0.11 |
| Q3 2026 | 1 | $0.12 | $0.15 | $0.13 |
| Q4 2026 | 1 | $0.16 | $0.20 | $0.17 |
| Q1 2027 | 1 | $0.27 | $0.34 | $0.30 |
| Q2 2027 | 1 | $0.32 | $0.40 | $0.35 |
| Q3 2027 | 1 | $0.35 | $0.44 | $0.38 |
| Q4 2027 | 1 | $0.38 | $0.48 | $0.41 |
| Q1 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 2 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 2 | $0.00 | $0.00 | $0.00 |
Zevra Therapeutics Inc Earnings Date And Information
Zevra Therapeutics Inc last posted its earnings results on Monday, March 9th, 2026. The company reported $1.16 earnings per share for the quarter, topping analysts' consensus estimates of $0.0504 by $1.1096. The company had revenue of 34.13 M for the quarter and had revenue of 106.47 M for the year. Zevra Therapeutics Inc has generated $1 earnings per share over the last year ($1.35 diluted earnings per share) and currently has a price-to-earnings ratio of 7.41. Zevra Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Zevra Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/09/2026 | Q4 2025 | $0.05 | $0.21 | 0.16 | $28.05 M | $34.13 M |
| 11/05/2025 | Q3 2025 | -$0.02 | -$0.01 | 0.01 | $26.63 M | $26.06 M |
| 08/12/2025 | Q2 2025 | $2.19 | $1.36 | -0.83 | $22.56 M | $25.88 M |
| 05/13/2025 | Q1 2025 | -$0.21 | -$0.06 | 0.15 | $16.91 M | $20.40 M |
| 03/12/2025 | Q4 2024 | N/A | -$0.67 | N/A | $8.93 M | $12.04 M |
| 11/13/2024 | Q3 2024 | N/A | -$0.69 | N/A | $4.87 M | $3.70 M |
| 08/13/2024 | Q2 2024 | N/A | -$0.48 | N/A | $4.37 M | $4.45 M |
| 05/09/2024 | Q1 2024 | N/A | -$0.40 | N/A | $3.76 M | $3.43 M |
| 04/01/2024 | Q4 2023 | N/A | -$0.40 | N/A | N/A | $13.22 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.30 | N/A | N/A | $2.90 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.15 | N/A | N/A | $8.47 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.34 | N/A | N/A | $3.18 M |
| 12/31/2022 | Q4 2022 | N/A | -$0.26 | N/A | N/A | $2.32 M |
| 09/30/2022 | Q3 2022 | N/A | -$0.19 | N/A | N/A | $2.87 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.70 | N/A | N/A | $1.30 M |
| 03/31/2022 | Q1 2022 | N/A | -$0.05 | N/A | N/A | $3.97 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.08 | N/A | N/A | $2.58 M |
| 09/30/2021 | Q3 2021 | N/A | -$0.05 | N/A | N/A | $1.97 M |
| 06/30/2021 | Q2 2021 | N/A | $0.21 | N/A | N/A | $11.99 M |
| 03/31/2021 | Q1 2021 | N/A | -$0.54 | N/A | N/A | $12.12 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zevra Therapeutics Inc Earnings: FAQ's
In the previous quarter, Zevra Therapeutics Inc (:ZVRA) reported $1.16 earnings per share (EPS) to beat the analysts' consensus estimate of $0.0504 by $1.1096.
The conference call for Zevra Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Zevra Therapeutics Inc's latest earnings report can be read online.
Zevra Therapeutics Inc (:ZVRA) has a recorded annual revenue of $106.47 M.
Zevra Therapeutics Inc (:ZVRA) has a recorded net income of $83.23 M.Zevra Therapeutics Inc has generated $1.4 earnings per share over the last four quarters.
Zevra Therapeutics Inc (:ZVRA) has a price-to-earnings ratio of 7.41 and price/earnings-to-growth ratio is 0.